16 C
Vientiane
Tuesday, January 13, 2026
spot_img

/DISREGARD RELEASE: Arkbio/

This Week

We are advised by Arkbio that journalists and other readers should disregard the news release, Ark Biopharmaceutical Receives China Marketing Authorization for Azstarys® for the Treatment of ADHD, issued on Jan. 6, 2026 by Arkbio over PR Newswire, as the release contained inappropriate information.

Latest article